2019 Emerging Hemostasis Testing Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers
This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for hemostasis testing.
The report also includes strategic assessments of current and emerging suppliers of hemostasis products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Chromogenic Substrates
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Dot Immunobinding Assays
- Capillary Immunoassays
- Enzyme Amplification
- Electrochemical Immunoassay
d. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- Fluorescence Lifetime
e. Latex Agglutination
f. Immunoprecipitation
Microcomputers
Automation
Robotics
DNA Probes
a. Overview
b. Amplification Methods
- PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- NASBA
- SDA
- 3 SR
- HPA
- Two-Tiered System
- LAT
Artificial Intelligence
Dry Chemistry
Biosensors
Competitive Profiles
- Abbott
- ADI/American Diagnostica
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data Corporation
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- Hyphen BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fisher
- ZyCare/Alere
2020 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View Report2024 Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new seven-country study contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
USD 24500 View ReportEmerging Hemostasis Testing Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019
This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for hemostasis testing.The report also includes strategic
USD 3850 View ReportEmerging Hemostasis Diagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019
This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.The report also includes strategic
USD 3850 View ReportFill The Form For Sample Request